Article Correctness Is Author's Responsibility: NICE recommends Vifor Pharma’s Veltassa® (patiromer)

(Cello Health PR) The National Institute for Health and Care Excellence (NICE) has published a final appraisal determination (FAD) recommending Veltassa® (patiromer) for the treatment of hyperkalaemia in adults, within the National Health Service (NHS) in England.